检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张学仪[1] ZHANG Xueyi(Department of Hand-foot Vascular Surgery,Jilin Hospital of Integrated Traditional Chinese and Western Medicine,Jilin Province,Jilin 132012,China)
机构地区:[1]吉林省吉林中西医结合医院手足血管外科,吉林吉林132012
出 处:《中国中医药现代远程教育》2023年第14期136-138,共3页Chinese Medicine Modern Distance Education of China
摘 要:目的 分析下肢动脉硬化闭塞症(Atherosclerosis occlusion,ASO)行自拟益气活血通痹方合硫酸氢氯吡格雷片治疗的价值。方法 选择80例患者为研究对象,分观察组(自拟益气活血通痹方合硫酸氢氯吡格雷片)40例、对照组(硫酸氢氯吡格雷片)40例,观察治疗效果。结果 对照组临床指标低于观察组(P<0.05);对照组血清炎症指标高于观察组(P<0.05);对照组的总有效率75.00%(30/40)低于观察组的97.50%(39/40)(P<0.05)。结论 下肢ASO患者采取自拟益气活血通痹方合硫酸氢氯吡格雷片治疗,可以改善患者的炎性因子水平、踝肱指数(ABI)、最大步行距离(MWD),提升效果,临床价值高。Objective To analyze the value of Yiqi Huoxue Tongbi prescription combined with clopidogrel bisulfate tablets in the treatment of arteriosclerosis obliterans(ASO)of lower limbs.Methods 80 patients were selected as the study objects,and they were divided into observation group of 40 cases(Yiqi Huoxue Tongbi prescription combined with clopidogrel bisulfate tablet)and control group of 40 cases(clopidogrel bisulfate tablet).The therapeutic effect was compared.Results The clinical indexes of the control group were lower than those of the observation group(P<0.05).The serum inflammation index of the control group was higher than that of the observation group(P<0.05).The total effective rate of control group was 75.00%(30/40),which was lower than that of observation group(97.50%,39/40)(P<0.05).Conclusion Yiqi Huoxue Tongbi prescription combined with clopidogrel bisulfate tablets in the treatment of ASO of lower limbs can improve inflammatory factors and factors,can effectively improve the index of ankle and brachial and maximum walking distance,improve the therapeutic effect,and have high clinical value.
关 键 词:益气活血通痹方 硫酸氢氯吡格雷片 下肢动脉硬化闭塞症 脉痹 中西医结合疗法
分 类 号:R543.5[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222